Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8260479 | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2014 | 11 Pages |
Abstract
Conclusion: Classical NF-κB activation impairs skeletal muscle OXPHEN by reducing IKK-α expression. TNF-α-induced reductions in muscle IKK-α may accelerate muscle OXPHEN deterioration in COPD.
Keywords
HMBSPPARHBSSFVCGUSBIL-1βTFAMIκBαHprtPPIAMLCPGC-1b2mNF-κBALAS1MyHCYWHAZIKK-βCOXIVUBCRPL13Aubiquitin CPeptidylprolyl isomerase A (cyclophilin A)IKK-αTnf-α, Tumour necrosis factor alphaFEV1PBSNRFDMEMICAM-1GFPOXPHOSGAPDHDulbecco's modified Eagle MediumGAPDH, glyceraldehyde-3-phosphate dehydrogenasePPAR, Peroxisome proliferator-activated receptorTFAM, mitochondrial transcription factor AAdenosine TriphosphateATPadenoviralstandard deviationinterleukin 1βChronic obstructive pulmonary diseaseCOPDforced expiratory volume in one secondHADmyosin light chainMyosin heavy chainconstitutively activeCitrate synthasebody mass indexBMIforced vital capacityNuclear respiratory factorSkeletal muscleActbTNF-αnuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alphanuclear factor kappa BOxidative phosphorylationOxidative metabolismPhosphate-buffered salineHank's balanced salt solutionSEMnot significantwild-typehydroxymethylbilane synthasegreen fluorescent protein
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
A.H.V. Remels, H.R. Gosker, R.C. Langen, M. Polkey, P. Sliwinski, J. Galdiz, B. van den Borst, N.A. Pansters, A.M.W.J. Schols,